Literature DB >> 1612197

Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels.

M C Pouliot1, J P Després, A Nadeau, S Moorjani, D Prud'Homme, P J Lupien, A Tremblay, C Bouchard.   

Abstract

The relations of regional adipose tissue (AT) distribution measured by computed tomography (CT) to plasma insulin-glucose homeostasis and lipoprotein-lipid levels were studied in 58 obese and 29 lean control men. In the group of obese men, the visceral AT area measured by CT was positively correlated with fasting plasma triglyceride and insulin levels and with glucose and insulin areas under the curves measured during a 75-g oral glucose tolerance test. Visceral AT area was also negatively associated with plasma high-density lipoprotein (HDL) and HDL2 cholesterol levels. The relative accumulation of abdominal fat, estimated by the ratio of abdominal to femoral AT areas obtained by CT, was also a significant correlate of indices of carbohydrate metabolism and was the best univariate correlate of plasma lipoprotein levels. No significant associations were observed between the visceral AT area, the ratio of abdominal to femoral AT areas, and indices of carbohydrate and lipoprotein metabolism in the group of lean men. On the other hand, the subcutaneous abdominal AT area was a significant correlate of the glucose area under the curve in both groups of men, but this association was not independent from the percentage of total body fat. No relationship was observed between the femoral AT area and indices of carbohydrate metabolism in either lean or obese groups. In obese men, however, the femoral AT area was negatively correlated with plasma triglyceride concentration and positively correlated with plasma HDL and HDL2 cholesterol levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612197     DOI: 10.2337/diab.41.7.826

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  110 in total

Review 1.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.

Authors:  Alexis Cutchins; Daniel B Harmon; Jennifer L Kirby; Amanda C Doran; Stephanie N Oldham; Marcus Skaflen; Alexander L Klibanov; Nahum Meller; Susanna R Keller; James Garmey; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 3.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Independent effects of age-related changes in waist circumference and BMI z scores in predicting cardiovascular disease risk factors in a prospective cohort of adolescent females.

Authors:  David J Tybor; Alice H Lichtenstein; Gerard E Dallal; Stephen R Daniels; Aviva Must
Journal:  Am J Clin Nutr       Date:  2010-12-08       Impact factor: 7.045

5.  [History and definition(s) of metabolic syndrome].

Authors:  M Hanefeld; F Schaper; A Ceriello
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

6.  Heterogeneous glycaemic and insulinaemic responses to oral glucose in non-diabetic men: interactions between duration of obesity, body fat distribution and family history of diabetes mellitus.

Authors:  S Lemieux; J P Després; A Nadeau; D Prud'homme; A Tremblay; C Bouchard
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 7.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 8.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 9.  Impact of obesity and bariatric surgery on metabolism and coronary circulatory function.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Freimut D Jüngling; Giuseppe Ambrosio; Richard Wahl; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

10.  Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study.

Authors:  L Bouchard; S J Weisnagel; J C Engert; T J Hudson; C Bouchard; M C Vohl; L Pérusse
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.